Smith Capital Management’s Pfizer PFE Stock Holding History

Smith Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$468K	Sell	13,445 -580	-4%	-$20.3K	0.29%	54
2020 Q2	$435K	Sell	14,025 -185	-1%	-$6.29K	0.29%	58
2020 Q1	$440K	Sell	14,210 -1,163	-8%	-$39.6K	0.33%	52
2019 Q4	$571K	Sell	15,373 -112	-0.7%	-$3.99K	0.36%	46
2019 Q3	$528K	Buy	15,485 +628	+4%	+$22.8K	0.39%	46
2019 Q2	$611K	Buy	14,857 +1,493	+11%	+$59.3K	0.45%	43
2019 Q1	$538K	Buy	13,364 +391	+3%	+$15.7K	0.42%	43
2018 Q4	$537K	Buy	+12,973	New	+$539K	0.44%	39

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Smith Capital Management's PFE Position: Q3 2020 in Review

Smith Capital Management reduced its Pfizer (PFE) stake by 4.1% in Q3 2020, selling an estimated $20.3K and leaving 13,445 shares worth $468K. The position accounts for 0.29% of the portfolio, ranked #54.

Smith Capital Management first reported a position in PFE in Q4 2018 and has held it in 8 quarters since. The position peaked at $611K in Q2 2019. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Smith Capital Management held 13,445 shares of Pfizer worth $468K as of Q3 2020.
Smith Capital Management sold 580 Pfizer shares in Q3 2020, an estimated $20.3K.
Pfizer made up 0.29% of Smith Capital Management's portfolio in Q3 2020, its #54 holding.
Smith Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 8 quarters since.
Smith Capital Management's Pfizer position peaked at $611K in Q2 2019.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Smith Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.